Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 16 tags : Disease save search
InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Prevention in combination with the CGuard™ Stent Platform & MicroNet™ Portfolio
Published: 2022-03-16 (Crawled : 21:00) - globenewswire.com
NSPR 4 | $1.91 -8.01% 14K
|
Health Technology
|
| O: -2.69%
H: 12.65%
C: 11.07%
disease stroke one platform
Biogen Announces Peer-Reviewed Publication of ADUHELM® Phase 3 EMERGE and ENGAGE Data in The Journal of Prevention of Alzheimer’s Disease
Published: 2022-03-16 (Crawled : 16:00) - globenewswire.com
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: 1.96%
H: 1.5%
C: 1.28%
aduhelm alzheimer disease phase 3 merge alzheimer’s alzheimer's disease alzheimer's
Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
Published: 2022-03-16 (Crawled : 14:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.87%
H: 0.27%
C: -0.51%
jardiance pos kidney trial disease positive
Clarus Announces Initiation of Phase 4 Clinical Trial of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadal Men with Chronic Kidney Disease
Published: 2022-03-16 (Crawled : 13:30) - biospace.com/
CRXT | $0.0475
|
|
| O: 0.23%
H: 10.43%
C: 7.06%
jatenzo treatment kidney trial disease one test
Long-Term Phase 3 Data Show ADUHELM® Continues to Reduce Underlying Pathologies of Alzheimer’s Disease in Patients Treated for More Than Two Years
Published: 2022-03-16 (Crawled : 12:00) - globenewswire.com
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: 1.96%
H: 1.5%
C: 1.28%
aduhelm alzheimer disease phase 3 alzheimer’s alzheimer's disease alzheimer's
AC Immune Reports First Live Images of Alpha-Synuclein in Human Brain with New PET Tracer for Neurodegenerative Disease at AD/PDTM Conference
Published: 2022-03-16 (Crawled : 12:00) - globenewswire.com
ACIU | $2.38 -1.65% -1.68% 190K
|
Health Technology
|
| O: 1.34%
H: 1.59%
C: 1.59%
trace conference disease neurodegenerative report alpha-synuclein aci-12589 train
Amicus Therapeutics Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease at the 2022 MDA Clinical & Scientific Conference
Published: 2022-03-16 (Crawled : 11:00) - globenewswire.com
FOLD 4 | $10.7 -1.11% -1.12% 3.2M
|
Health Technology
|
| O: 1.34%
H: 4.74%
C: 4.74%
pos conference therapeutics disease phase 1 positive
Carrier Screening Market - 2022-2026 | Rising Prevalence of Genetic Diseases and Disorders to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-03-16 (Crawled : 11:00) - prnewswire.com
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
|
| O: 2.88%
H: 1.64%
C: 1.03%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.78%
H: 1.13%
C: 1.07%
genetic order research disease genetic disease report growth
Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022
Published: 2022-03-16 (Crawled : 10:00) - globenewswire.com
PRTA 4 | $20.565 -3.41% -3.53% 440K
|
Health Technology
|
| O: 1.17%
H: 5.93%
C: 5.9%
alzheimer program parkinson disease alzheimer’s alzheimer's
Neuromuscular Disease Therapeutics Market to Grow by USD 4.46 bn | Technavio
Published: 2022-03-16 (Crawled : 03:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
BCLI A | $0.531 -1.69% -1.71% 170K
|
Health Technology
|
| O: 3.25%
H: 2.52%
C: 2.2%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: 1.96%
H: 1.5%
C: 1.28%
therapeutics disease
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.